Skip to main content
EMBO Reports logoLink to EMBO Reports
. 2017 Sep 1;18(9):1671. doi: 10.15252/embr.201744761

Glioma‐derived cancer stem cells are hypersensitive to proteasomal inhibition

Young Dong Yoo, Dae‐Hee Lee, Hyunjoo Cha‐Molstad, Hyungsin Kim, Su Ran Mun, Changhoon Ji, Seong Hye Park, Ki Sa Sung, Seung A Choi, Joonsung Hwang, Deric M Park, Seung Ki Kim, Kyung‐Jae Park, Shin‐Hyuk Kang, Sang Cheul Oh, Aaron Ciechanover, Yong J Lee, Bo Yeon Kim, Yong Tae Kwon
PMCID: PMC5579352  PMID: 28864661

Abstract

graphic file with name EMBR-18-1671-g001.jpg

Subject Categories: Autophagy & Cell Death, Cancer, Stem Cells


The affiliations of Joonsung Hwang, Deric Park and Bo Yeon Kim were listed incorrectly. The authors have confirmed that JH and BYK are affiliated with World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience & Biotechnology, Ochang Cheongwon, Korea. These authors have never been affiliated with Korea University Department of Neurosurgery. DP is affiliated with Neuro‐Oncology Branch, CCR, NCI, National Institutes of Health in addition to the University of Virginia. The authors apologise for any inconvenience caused.


Articles from EMBO Reports are provided here courtesy of Nature Publishing Group

RESOURCES